Novo Says Still Some Uncertainty on Tresiba Costs
Oct. 31 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about the company's third-quarter profit reported today, sales forecast and the launch of its new diabetes treatment, Tresiba. He speaks from Bagsvaerd, Denmark, with Caroline Hyde on Bloomberg Television's "The Pulse." (Source: Bloomberg)
Most Recent Videos
Arnab Das: EM, Mexico Fear Trump Saying 'You’re Fired'
41:38 - In today's "Morning Must Read," Bloomberg’s Anna Edwards highlights comments from Morgan Stanley Chief Executive Officer James Gorman on the U.S. presidential election. She speaks with Arnab Das, head of Emerging Markets macro research at Invesco Asset Management, on "Bloomberg Surveillance." (Source: Bloomberg)